By Emeritus Professor Shane Darke

Books

Ross JE; Darke S; Hall W, 1995, Benzodiazepine use among heroin users in Sydney: Patterns, availability and preferences, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/TR.027.pdf

Darke S; Hall W; Ross JE, 1995, The Injection of Methadone Syrup in Sydney, Australia, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia

Darke S; Ross JE; Cohen J; Hall W, 1994, Context and Correlates of Non Fatal Overdose Among Heroin Users in Sydney, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/Mono.20.pdf

Ross JE; Cohen J; Darke S; Hando J; Hall W, 1994, Transitions Between Routes of Administration and Correlates of Injecting Amongst Regular Amphetamine Users in Sydney, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/Mono.18.pdf

Book Chapters

Darke S, 2021, 'Learning from the dead: How death provides insights into alcohol-related harm', in The Handbook of Alcohol Use, Elsevier, pp. 141 - 153, http://dx.doi.org/10.1016/b978-0-12-816720-5.00020-7

Maloney EA; Darke S, 2010, 'Psychosocial risk factors for suicide attempts among drug users', in Sher L; Vilens A (ed.), Suicidal Behavior in Alcohol and Drug Abuse and Dependence, Nova Sciences, New York, pp. 285 - 297

Darke S, 2010, 'Scales for research in the addictions', in Miller PG; Strang J; Miller PM (ed.), Addiction Research Methods, Wiley-Blackwell, Chichester, West Sussex, U.K., pp. 127 - 145

Darke S, 2008, 'Suicide: The hidden issue', in Drug use and Mental Health: Effective Responses to Co-occurring Drug and Mental Health Problems, IP Communications, Melbourne, pp. 143 - 149

Darke S, 2002, 'UK Drugs Unlimited: New Research and Policy Lessons on Illicit Drug Use', in Addiction, Blackwell Publishing Ltd, Oxford, England, pp. 240 - 241

Darke S, 1998, 'The effectiveness of methadone maintenance treatment 3: Moderators of treatment outcome', in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, Harwood Academic Publishers, The Netherlands, pp. 75 - 89

Ross JE; Darke S; Hall W, 1996, 'Benzodiazepine injecting among heroin users', in Topp L; Dillon P (ed.), Looking to the future: A second generation of drug research. Proceedings from the Tenth National Drug and Alcohol Research Centre Annual Symposium, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia

Journal articles

Darke S; Farrell M; Hall W; Lappin J, 2025, '‘Deaths of despair’: A term that needs to be retired', Addiction, 120, pp. 1072 - 1074, http://dx.doi.org/10.1111/add.70030

Darke S; Peacock A; Duflou JA; Farrell M; Lappin J, 2025, 'Methylphenidate and (lis)dexamfetamine toxicity-related deaths of adults, Australia, 2000–24: analysis of NCIS data', Medical Journal of Australia, 222, pp. 259 - 261, http://dx.doi.org/10.5694/mja2.52604

Darke S; Farrell M; Lappin J, 2025, 'Rare but relevant series', Addiction, 120, pp. 197, http://dx.doi.org/10.1111/add.16697

Darke S; Duflou J; Chrzanowska A; Farrell M; Lappin J; Peacock A, 2025, 'Changes in the rates and characteristics of gamma hydroxybutyrate (GHB)-related death in Australia, 2001–2023', Drug and Alcohol Review, 44, pp. 366 - 375, http://dx.doi.org/10.1111/dar.13940

Darke S; Duflou J; Peacock A; Lim J; Havard A; Farrell M; Lappin J, 2025, 'Characteristics of deaths related to lithium toxicity in Australia, 2000–2024', Australian and New Zealand Journal of Psychiatry, http://dx.doi.org/10.1177/00048674251336037

Roberts E; Copeland C; Darke S; Farrell M, 2025, 'Characteristics of drug-related deaths where individuals are found submerged in a bath or hot tub in the United Kingdom, 1997–2023', Drug and Alcohol Review, 44, pp. 347 - 354, http://dx.doi.org/10.1111/dar.13950

Zahra E; Darke S; Lappin J; Duflou J; Farrell M, 2024, 'Baclofen-related deaths in Australia 2000–2022', Forensic Science International, 365, http://dx.doi.org/10.1016/j.forsciint.2024.112281

Darke S; Duflou J; Farrell M; Lappin J; Peacock A, 2024, 'Emergence of deaths due to nitazene toxicity in Australia', Drug and Alcohol Review, 43, pp. 2093 - 2094, http://dx.doi.org/10.1111/dar.13920

Darke S; Duflou J; McDonald S; Peacock A; Farrell M; Lappin J, 2024, 'Neuropathology of deaths due to acute alcohol toxicity in Australia, 2011–2022', Drug and Alcohol Dependence, 263, http://dx.doi.org/10.1016/j.drugalcdep.2024.111407

Marel C; Wilson J; Darke S; Ross J; Slade T; Haber PS; Haasnoot K; Visontay R; Keaveny M; Tremonti C; Mills KL; Teesson M, 2024, 'Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence: Key Findings from the 18–20-Year Follow-Up of the Australian Treatment Outcome Study (ATOS)', International Journal of Mental Health and Addiction, 22, pp. 2565 - 2582, http://dx.doi.org/10.1007/s11469-022-01006-6

Darke S; Duflou J; Peacock A; Farrell M; Hall W; Lappin J, 2024, 'A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia', Addiction, 119, pp. 1564 - 1571, http://dx.doi.org/10.1111/add.16518

Darke S; Farrell M; Duflou J; Lappin J, 2024, 'Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications', Addiction, 119, pp. 1153 - 1155, http://dx.doi.org/10.1111/add.16407

Darke S; Duflou J; Peacock A; Chrzanowska A; Yuen WS; Farrell M; Lappin J, 2024, 'Characteristics, toxicology and major organ pathology of deaths due to acute alcohol toxicity in Australia, 2011–2022', Drug and Alcohol Review, 43, pp. 937 - 945, http://dx.doi.org/10.1111/dar.13817

Hall W; Darke S; Farrell M, 2024, 'Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders?', Addiction, 119, pp. 786 - 787, http://dx.doi.org/10.1111/add.16416

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2024, 'A descriptive coronial study of heroin toxicity deaths in Australia, 2020–2022: Characteristics, toxicology and survival times', Addiction, 119, pp. 559 - 569, http://dx.doi.org/10.1111/add.16377

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2024, 'Differences in heroin overdose deaths in Australia by age, 2020-2022: Disease and estimated survival times', DRUG AND ALCOHOL DEPENDENCE REPORTS, 10, http://dx.doi.org/10.1016/j.dadr.2024.100217

Bharat C; Webb P; Wilkinson Z; McKetin R; Grebely J; Farrell M; Holland A; Hickman M; Tran LT; Clark B; Peacock A; Darke S; Li JH; Degenhardt L, 2023, 'Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysis', Addiction, 118, pp. 1624 - 1648, http://dx.doi.org/10.1111/add.16200

Darke S; Farrell M; Lappin J, 2023, 'Overdose and suicide are different phenomena among opioid users that require different clinical management', Australian and New Zealand Journal of Psychiatry, 57, pp. 1095 - 1100, http://dx.doi.org/10.1177/00048674231159298

Lappin JM; Darke S; Farrell M, 2023, 'Psychotogenic potential of prescribed drugs', Australian and New Zealand Journal of Psychiatry, 57, pp. 777 - 779, http://dx.doi.org/10.1177/00048674231174807

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2023, 'Characteristics and circumstances of cocaine-related completed suicide in Australia, 2000–2021', Drug and Alcohol Dependence, 244, http://dx.doi.org/10.1016/j.drugalcdep.2023.109803

Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2023, 'Clinical characteristics of fatal cocaine toxicity in Australia, 2000–2021', Drug and Alcohol Review, 42, pp. 582 - 591, http://dx.doi.org/10.1111/dar.13581

Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2023, 'Rates, characteristics and toxicology of cocaine-related deaths in Australia, 2000–2021', Addiction, 118, pp. 297 - 306, http://dx.doi.org/10.1111/add.16055

Darke S; Zahra E; Duflou J; Peacock A; Farrell M; Lappin J, 2023, 'Characteristics and circumstances of volatile solvent misuse-related death in Australia, 2000–2021', Clinical Toxicology, 61, pp. 260 - 265, http://dx.doi.org/10.1080/15563650.2023.2184243

Lappin JM; Zahra E; Darke S; Shand F; Sharma S; Draper B; Connors MH; Dear B; Titov N; Campbell G, 2022, 'Presentations to the emergency department with self-harm or suicidal behaviours: A role for digital mental health services?', Journal of Psychiatric Research, 154, pp. 50 - 55, http://dx.doi.org/10.1016/j.jpsychires.2022.07.046

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal tapentadol-related toxicity in Australia', Drug and Alcohol Review, 41, pp. 1071 - 1077, http://dx.doi.org/10.1111/dar.13462

Darke S; Chrzanowska A; Campbell G; Zahra E; Lappin J, 2022, 'Barbiturate-related hospitalisations, drug treatment episodes, and deaths in Australia, 2000‒2018', Medical Journal of Australia, 216, pp. 194 - 198, http://dx.doi.org/10.5694/mja2.51306

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ synthetic opioid toxicity in Australia', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109292

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ benzodiazepine toxicity in Australia', Forensic Science International, 331, http://dx.doi.org/10.1016/j.forsciint.2021.111140

Weatherburn D; Darke S; Zahra E; Farrell M, 2022, 'Who would try (or use more) cannabis if it were legal?', Drug and Alcohol Review, 41, pp. 386 - 395, http://dx.doi.org/10.1111/dar.13360

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal gabapentinoid-related poisoning in Australia, 2000–2020', Clinical Toxicology, 60, pp. 304 - 310, http://dx.doi.org/10.1080/15563650.2021.1965159

Darke S; Banister S; Farrell M; Duflou J; Lappin J, 2021, '‘Synthetic cannabis’: A dangerous misnomer', International Journal of Drug Policy, 98, pp. 103396, http://dx.doi.org/10.1016/j.drugpo.2021.103396

Campbell G; Darke S; Hall W; Lappin J, 2021, 'Increased barbiturate deaths: an unintended consequence of increased publicity for methods of do-it-yourself euthanasia?', Addiction, 116, pp. 3273 - 3275, http://dx.doi.org/10.1111/add.15573

Chrzanowska A; Man N; Darke S; Degenhardt L; Farrell M; Moran L; Peacock A, 2021, 'Unintentional and intentional drug poisoning deaths, Australia, 2012–2016: Drug pattern profile and demographic characteristics', Drug and Alcohol Dependence, 229, http://dx.doi.org/10.1016/j.drugalcdep.2021.109112

Geddes L; Iversen J; Darke S; Dietze P; Maher L, 2021, 'Prevalence and correlates of multiple non-fatal opioid overdoses among people who inject drugs who utilise needle syringe programs in Australia', International Journal of Drug Policy, 96, pp. 103245, http://dx.doi.org/10.1016/j.drugpo.2021.103245

Lappin JM; Darke S, 2021, 'Methamphetamine and heightened risk for early-onset stroke and Parkinson's disease: A review', Experimental Neurology, 343, pp. 113793, http://dx.doi.org/10.1016/j.expneurol.2021.113793

Campbell G; Darke S; Zahra E; Duflou J; Shand F; Lappin J, 2021, 'Trends and characteristics in barbiturate deaths Australia 2000-2019: a national retrospective study', Clinical toxicology (Philadelphia, Pa.), 59, pp. 224 - 230, http://dx.doi.org/10.1080/15563650.2020.1789653

Darke S; Duflou J; Farrell M; Peacock A; Lappin J; Peacock A, 2021, 'Characteristics and circumstances of death related to the self-administration of ketamine', Addiction, 116, pp. 339 - 345, http://dx.doi.org/10.1111/add.15154

Darke S; Duflou J; Larance B; Farrell M; Lappin J, 2021, 'Characteristics and circumstances of death related to buprenorphine toxicity in Australia', Drug and Alcohol Dependence, 218, http://dx.doi.org/10.1016/j.drugalcdep.2020.108360

Darke S; Peacock A; Duflou J; Farrell M; Lappin J; Peacock A, 2020, 'Characteristics and circumstances of death related to gamma hydroxybutyrate (GHB)', Clinical Toxicology, 58, pp. 1028 - 1033, http://dx.doi.org/10.1080/15563650.2020.1726378

Back to profile page